Thrombocytosis

Thrombocytosis

Thrombocytosis is a term used to describe an elevated blood platelet count and could be either permanent or persistent, depending on the root reason. Platelets, also known as thrombocytes are essential components of the bone marrow. They help to stop bleeding by forming blood clots. If the production of platelets is greater than normal levels, it could be a sign of a health issue or a bone marrow disease.

Types of Thrombocytosis

There are two major categories:

  • Reactive (Secondary) Thymombocytosis The most prevalent type. It’s generally a result of an other medical issue like inflammation and infection, bleeding or some cancers. It’s usually temporary and will resolve once the root issue is resolved.

  • Primary Thrombocytosis (Essential Thrombocythemia): This is a rare blood disorder that is caused by an abnormal growth of cells in the bone marrow. It’s frequently resulting from gene mutations (e.g., JAK2, CALR MPL, JAK2). In contrast to reactive thrombocytosis it is a chronic condition that requires continuous monitoring and management.

Common Causes

Reactive Thrombocytosis

  • Chronic or acute infection

  • A major operation or trauma

  • Anemia due to iron deficiency

  • Chronic inflammation conditions (e.g. Rheumatoid arthritis, rheumatoid arthritis IBD, etc.)

  • Cancer

  • Hemolytic anemia

  • Post-splenectomy (after the removal of the spleen)

Essential Thrombocythemia

  • Bone marrow genetic mutations that affect regulation

  • Myeloproliferative Neoplasms

  • Idiopathic bone marrow diseases

Symptoms

A majority of patients with thrombocytosis be asymptomatic, particularly when it is a reactive case. When symptoms do show up especially in the case of essential thrombocythemia, they might be:

  • Headaches that persist

  • The feeling of fainting or dizziness can be a cause.

  • Numbness or tingling sensations in extremities

  • Visual disturbances

  • The chest may be painful or it may feel short of breath

  • Unusual bleeding or bruises

In the most severe instances bleeding forms clots (thrombosis) as well as bleeding-related complications may be present, causing damage to the heart, brain, or the lungs.

Diagnosis

Thrombocytosis is usually diagnosed through routine blood tests that reveal an increase in platelet count (typically at or above the threshold of 450,000 plates per microliter). Additional tests are performed to determine the nature and its cause, including:

  • Total Blood count (CBC)

  • Blood smears from the peripheral blood vessels

  • Studies on iron

  • Markers of inflammation (e.g. CRP, ESR)

  • Genetic testing (JAK2 CALR, MPL mutations)

  • Bone Marrow biopsies (in suspecting essential thrombocythemia)

Treatment Options

For Reactive Thrombocytosis

The emphasis is on controlling the condition that is causing it. Treatment usually isn’t targeted at the elevated platelet count, unless complications occur.

  • Infections or inflammation can be treated

  • Iron supplementation in deficiency states

  • Do not discontinue medications that are known to raise platelets

  • Monitoring the levels of platelets regularly

For Essential Thrombocythemia

Management is designed to minimize the chance of clotting or bleeding. It is dependent on the patient’s health, age and the platelet count.

  • Low-dose aspirin: Helps prevent clot formation in low-risk patients

  • The treatment of cytoreductive The use of drugs like interferon alpha and hydroxyurea are utilized to decrease the production of platelets in patients at risk.

  • JAK inhibitors In some cases drugs like ruxolitinib can be considered

  • Changes in lifestyle managing the risk of cardiovascular disease (blood pressure (hypertension, smoking, diabetes)

Prognosis and Monitoring

Reactive thrombocytosis typically disappears once the cause is identified and it has a positive prognosis. Essential thrombocythemia needs to be monitored for life because of the potential for complications such as blood clots, or the progression of more grave blood conditions (e.g. myelofibrosis, myelofibrosis, or acute leukemia).

Patients are urged to:

  • Regularly monitor your blood sugar levels

  • Do not smoke

  • Keep a heart-healthy and balanced lifestyle

  • Talk about any bleeding issues or neurological symptoms with your doctor right away.

Best Haematologist in India

About the Doctor

Dr. Padmaja Lokireddy is a highly respected Hemato Oncologist, Bone Marrow & Stem Cell Transplant Surgeon with years of experience in the field. She earned her postgraduate degree in internal medicine from the prestigious Manipal Academy of Higher Education and continued her studies and worked in the UK for about 13 years.

0
Years of experience


0
Patients Treated


0%
Success rate


AWARDS

India Brand Icon Award – 2020

India Brand Icon Award for Healthcare Excellence (Hemato-Oncology & Bone Marrow Transplant) By Time Cyber Media.

Meritorious Award

Meritorious Award in the field of Hematology and Transplant by International Biographic centre, Cambridge 2016.

International Biographic Dictionary, Cambridge

Included in International Biographic Dictionary, Cambridge and recognised in the top 100 physicians for 2016.

India Brand Icon Award – 2020

India Brand Icon Award for Healthcare Excellence (Hemato-Oncology & Bone Marrow Transplant) By Time Cyber Media.

Meritorious Award

Meritorious Award in the field of Hematology and Transplant by International Biographic centre, Cambridge 2016.

International Biographic Dictionary, Cambridge

Included in International Biographic Dictionary, Cambridge and recognised in the top 100 physicians for 2016.

Insights & Interviews: Bone Marrow Transplant Journey

Patient Testimonials & Success Stories

Frequently Asked Questions about Thrombocytosis

Thrombocytosis is a disorder characterized by the overproduction of platelets, which are blood particles involved in the formation of blood clots.

Most people with thrombocytosis do not experience symptoms. However, those with essential thrombocythemia may have symptoms related to blood clots and bleeding, such as headaches, dizziness, chest pain, weakness, and numbness or tingling in the hands and feet.

Thrombocytosis is often detected through routine blood tests. If your platelet levels are higher than normal, it is important to consult with your doctor to determine the underlying cause.

Thrombocytosis can be caused by various factors. Reactive thrombocytosis is commonly associated with conditions such as acute bleeding, cancer, infections, iron deficiency, inflammatory disorders, or surgery. The cause of essential thrombocythemia is unclear but is often linked to genetic mutations.

Thrombocytosis is typically diagnosed through a routine blood test that reveals a high platelet count. Further tests may be conducted to determine the underlying cause and differentiate between reactive thrombocytosis and essential thrombocythemia.

Essential thrombocythemia poses a higher risk of clotting or bleeding complications compared to reactive thrombocytosis. However, both types of thrombocytosis require proper management and monitoring.

The management of thrombocytosis depends on the underlying cause. Treatment may involve addressing the underlying condition, medications to control platelet production, or procedures to reduce platelet count.

Preventing thrombocytosis may not always be possible, as it can be caused by various factors. However, maintaining overall health, managing underlying conditions, and following your doctor's recommendations can help reduce the risk.

Thrombocytosis itself is not typically life-threatening, but complications such as blood clots or excessive bleeding can pose serious health risks. Proper diagnosis, management, and monitoring are essential to minimize these risks.